During an event in Hyderabad, Commerce Secretary Rajesh Agrawal emphasized the need for the Indian pharmaceutical industry to reduce its dependence on critical imported raw materials. He urged the sector to aim for 80-90% self-sufficiency in meeting domestic pharmaceutical requirements through indigenous production. Agrawal highlighted the importance of positioning India as a global hub for quality and cost-effective pharmaceuticals, which requires a robust quality ecosystem to build global trust. He called for a shift from a volume-driven to a value-driven industry, advocating for increased innovation and participation in developing new patents. The Indian pharmaceutical sector is currently the third-largest producer globally by volume, with exports reaching $30.47 billion in 2024-25, reflecting a 9.4% growth over the previous year. During the first eleven months of 2025-26, exports stood at $28.29 billion, marking over 5% growth compared to the same period last year.